Selectivity of immunomodulation by adriamycin.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000951:Antigens, Neoplasm / Q000276:immunology; D002478:Cells, Cultured; D004317:Doxorubicin / Q000494:pharmacology*; D005260:Female; D006462:Hemolytic Plaque Technique; D007111:Immunity, Cellular / Q000187:drug effects*; D051379:Mice; D008810:Mice, Inbred C57BL; D009369:Neoplasms / Q000276:immunology; D013154:Spleen / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects
D000951:Antigens, Neoplasm; D004317:Doxorubicin